Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/28005
Title: The new EU compulsory licensing regime needs to allow the export of medicines
Authors: Gurgula, O
Issue Date: 27-Nov-2023
Publisher: Medicines Law & Policy
Citation: Gurgula, O. (2023) 'The new EU compulsory licensing regime needs to allow the export of medicines', Medicines Law & Policy, 23 November, pp. 1 - 2. Available at: https://medicineslawandpolicy.org/2023/11/the-new-eu-compulsory-licensing-regime-needs-to-allow-the-export-of-medicines/ (accessed: 11 January 2024).
Abstract: A war-weary Ukraine critically depends on the support of the European Union (EU) in all spheres, especially in the provision of life-saving medicines to the Ukrainian population. The EU has pledged its support for Ukraine following Russia’s invasion. However, a recent proposal by the European Commission on a new EU-wide compulsory licensing regime (COM(2023) 224) may have the opposite effect.
URI: https://bura.brunel.ac.uk/handle/2438/28005
Appears in Collections:Brunel Law School Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf1.57 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons